21 CFR § 900.25 - Hearings and appeals.

---
identifier: "/us/cfr/t21/s900.25"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 900.25 - Hearings and appeals."
title_number: 21
title_name: "Food and Drugs"
section_number: "900.25"
section_name: "Hearings and appeals."
chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "I"
subchapter_name: "MAMMOGRAPHY QUALITY STANDARDS ACT"
part_number: "900"
part_name: "MAMMOGRAPHY"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "21 U.S.C. 360i, 360nn, 374(e); 42 U.S.C. 263b."
regulatory_source: "62 FR 55976, Oct. 28, 1997, unless otherwise noted. Republished and corrected at 62 FR 60614, Nov. 10, 1997."
cfr_part: "900"
---


# 900.25 Hearings and appeals.

(a) Opportunities to challenge final adverse actions taken by FDA regarding approval of certification agencies or withdrawal of approval of certification agencies shall be communicated through notices of opportunity for informal hearings in accordance with part 16 of this chapter.

(b) A facility that has been denied certification is entitled to an appeals process from the certification agency. The appeals process shall be specified in writing by the certification agency and shall have been approved by FDA in accordance with §§ 900.21 and 900.22.